Invention Grant
- Patent Title: Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
-
Application No.: US17833341Application Date: 2022-06-06
-
Publication No.: US11591353B2Publication Date: 2023-02-28
- Inventor: Abdelmalik Slassi , Joseph Araujo
- Applicant: Mindset Pharma Inc.
- Applicant Address: CA Toronto
- Assignee: Mindset Pharma Inc.
- Current Assignee: Mindset Pharma Inc.
- Current Assignee Address: CA Toronto
- Agency: Bereskin & Parr LLP/S.E.N.C.R.L., s.r.l.
- Agent Patricia Folkins
- Main IPC: C07D209/12
- IPC: C07D209/12 ; C07D403/06 ; C07F9/572 ; C07D209/16 ; C07D401/14
Abstract:
The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
Public/Granted literature
- US20220324889A1 PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS Public/Granted day:2022-10-13
Information query
